Integra LifeSciences
IART
208 hedge funds and large institutions have $897M invested in Integra LifeSciences in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 75 increasing their positions, 63 reducing their positions, and 44 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 63
1.14% less ownership
Funds ownership: 95.2% → 94.06% (-1.1%)
5% less funds holding
Funds holding: 219 → 208 (-11)
18% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 44
45% less capital invested
Capital invested by funds: $1.62B → $897M (-$720M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$39.4M |
| 2 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$11.6M |
| 3 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$8.02M |
| 4 |
Millennium Management
New York
|
+$6.07M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$5.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$38.1M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$29.2M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$20.9M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$18.2M |
| 5 |
Morgan Stanley
New York
|
-$12.7M |
IART Hedge Fund Activity: Q2 2025 in Review
208 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q2 2025, worth a combined $897M — down 45% from $1.62B a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of IART and 36 opened new positions — a net loss of 8 holders — while 63 trimmed existing stakes and 75 added.
The largest buyer was Rubric Capital Management (New York), adding an estimated $39.4M. The largest seller was AllianceBernstein, cutting an estimated $38.1M.
- 208 institutional investors held Integra LifeSciences (IART) as of Q2 2025, down from 219 in Q1 2025.
- Funds reported $897M of Integra LifeSciences stock for Q2 2025, down 45% quarter-over-quarter.
- 36 funds opened new Integra LifeSciences positions in Q2 2025 and 44 closed out, a net change of -8 holders.
- The largest Integra LifeSciences buyer in Q2 2025 was Rubric Capital Management (New York), an estimated $39.4M added.
- The largest Integra LifeSciences seller in Q2 2025 was AllianceBernstein, an estimated $38.1M sold.
Based on aggregated 13F filings for Q2 2025.